Hydration Claim Substantiation: Corneometer, Skicon & Moisture Mapping Methods

Overview #

Hydration claims are not marketing language. They are regulatory commitments, and the measurement method you choose determines whether your claim survives a challenge. We see this constantly — brands come to us with “72-hour hydration” on their brief, and when we ask what substantiation protocol they’re planning, the answer is usually silence. The instrumental method, the panel design, the timepoints, the statistical threshold — all of it has to be decided before the first batch is made, not after. Getting this right is one of the most underestimated parts of launching a moisturizer or serum in regulated markets.

Instrumental Methods: What the Machines Actually Measure #

Corneometer, Skicon, TEWL — brands hear these terms and assume they’re interchangeable. They’re not. Each measures a different physical property, and choosing the wrong one for your claim is a fast path to a study that proves nothing useful.

The Corneometer (CM 825, Courage + Khazaka) measures capacitance-based skin hydration in the stratum corneum. It reads in arbitrary units (AU), with baseline dry skin typically sitting around 20–35 AU and well-hydrated skin above 45 AU. In our lab, we use it as the primary endpoint for “moisturizing” and “hydrating” claims because it’s the most widely accepted method in EU dossier submissions under EU Cosmetics Regulation 1223/2009. The probe is sensitive to ambient humidity, so we run all measurements in a controlled room at 21°C ± 1°C and 45–50% RH. Skip that step and your inter-subject variability will eat your statistical power.

Skicon (IBS-320, Yayoi) measures conductance rather than capacitance. It’s more sensitive to the very surface of the stratum corneum — the top 10–20 µm — which makes it better for detecting fast-acting humectant effects. We use it as a secondary endpoint when a brand wants to substantiate an “instant hydration” or “immediate comfort” claim. The two instruments don’t always agree, and that’s not a problem — it’s information. When Corneometer goes up but Skicon doesn’t move, the hydration is deeper. When Skicon spikes and Corneometer lags, you’re looking at a surface film effect, not genuine stratum corneum water binding.

TEWL (transepidermal water loss), measured by Tewameter or VapoMeter, is the barrier function endpoint. It doesn’t measure hydration directly — it measures how fast water is escaping. For barrier repair claims, TEWL is the primary instrument. For pure hydration claims, it’s supporting data. We almost always include it anyway because a product that raises Corneometer readings while also increasing TEWL is doing something cosmetically questionable — you’re adding water but breaking the barrier to do it.

Moisture mapping is a different category entirely. It uses either multi-spectral imaging or confocal Raman spectroscopy to generate spatial hydration maps across a defined skin area — typically a 4 cm² zone on the volar forearm or cheek. We use it for premium product launches where the brand wants visual data for marketing, not just mean AU values. The Raman approach gives you depth profiling down to ~100 µm, which is genuinely useful for comparing film-forming vs. penetrating humectant systems. The limitation is cost and throughput — you can’t run 60 subjects through a Raman mapping protocol without a serious CRO budget.

For brands building their first hydration dossier, our standard recommendation is Corneometer as primary, TEWL as secondary, and a self-assessment questionnaire as the consumer perception arm. That combination covers most EU and FDA Cosmetics Guidelines substantiation requirements without overcomplicating the study design.

See also our formulation notes on hydration and moisture systems for how ingredient selection connects to these measurement endpoints.

Consumer Panel Design: Where Most Studies Fall Apart #

Honestly, most brands underestimate how much the panel design matters. A poorly designed study with a good product will generate weak data. We’ve seen it.

The minimum panel size for a statistically meaningful hydration claim — one that will hold up to retailer or regulatory scrutiny — is 30 subjects for a within-subject paired design. We prefer 40–50 to account for dropouts and to give enough power for subgroup analysis (dry vs. normal skin, for example). The SCCS Scientific Opinion on cosmetic efficacy testing doesn’t mandate a specific n, but 30 is the de facto floor that most EU notified bodies expect.

Inclusion criteria matter more than most brands realize. For a hydration study, you want subjects with baseline Corneometer readings below 40 AU — if you recruit people with already well-hydrated skin, you have no room to show improvement. This is a basic ceiling effect problem, and it kills more studies than any formulation issue. We now require CROs to confirm baseline stratification before we sign off on a protocol.

The washout period is another common failure point. Subjects need to stop using any leave-on moisturizer for at least 7 days before baseline measurement. Some protocols use 5 days — in our experience that’s not enough, especially for occlusive-heavy products. We’ve had one study where the washout was only 4 days and the baseline readings were so high that the active product showed no significant lift. The study was essentially useless. We now write 7-day minimum into every protocol we co-develop.

Timepoints for a standard hydration claim study: baseline (T0), 30 minutes post-application (T0.5), 2 hours (T2), 8 hours (T8), and 24 hours (T24). For a 72-hour claim, you add T48 and T72 — subjects come back to the lab without reapplying. For a “long-lasting” or “all-day” claim, T8 is usually the critical timepoint. If your product doesn’t hold at T8, the claim is hard to defend regardless of what happens at T2.

One clinical reference we cite regularly in our dossiers: a double-blind, vehicle-controlled study (n=44, 4-week daily use) evaluating a 5% sodium hyaluronate + 3% glycerin serum formulation showed a mean Corneometer increase of 28.4% from baseline at T24 versus 6.1% for vehicle. The effect was maintained at week 4 with a 31.2% improvement over baseline. That’s the kind of data structure — paired design, vehicle control, multiple timepoints, percentage change from baseline — that makes a claim dossier clean.

Before/After Photography: Useful Data or Marketing Theater? #

This is where we push back on briefs more than anywhere else.

Before/after photography is not a substitute for instrumental data. It’s supporting evidence, and only if the protocol is standardized. We’ve reviewed photography submissions from brands where the lighting changed between sessions, the subject’s head position shifted, and the skin prep was inconsistent. That data is worthless — worse than worthless, because it creates a false impression of rigor.

For photography to be usable in a claim dossier, you need a fixed imaging system. We work with VISIA Complexion Analysis (Canfield Scientific) or the Antera 3D for texture and hydration-related surface parameters. Fixed chin rest, fixed lighting geometry, fixed camera-to-skin distance. The subject’s skin must be clean and free of any product for at least 2 hours before imaging. Same time of day for all sessions — skin hydration has a diurnal variation of roughly 10–15% that will confound your data if you’re not controlling for it.

What photography actually captures well: surface texture changes, visible flakiness reduction, fine line appearance under standardized lighting. What it doesn’t capture: stratum corneum water content, TEWL, or anything below the skin surface. For a hydration claim, photography is the third tier of evidence, behind instrumental and consumer perception data.

The consumer perception questionnaire is actually more valuable than most brands give it credit for. A validated 10-point VAS (visual analogue scale) or a Likert-scale questionnaire covering “skin feels hydrated,” “skin feels comfortable,” “skin feels soft” — when administered to 40+ subjects with proper blinding — generates data that regulators and retailers both understand. It also connects the instrumental numbers to the consumer experience, which is what the claim is ultimately about.

We haven’t fully solved the correlation problem between Corneometer readings and consumer-perceived hydration. Our data suggests the relationship is real but nonlinear — subjects don’t reliably perceive a difference below about 8–10 AU change on the Corneometer. Above that threshold, perception scores track reasonably well. It’s not a perfect solution.

Designing a 12-Week Hydration Efficacy Study #

When a brand partner comes to us wanting a 12-week study, the first question we ask is: what claim are you trying to make, and in which market? A 12-week study for an EU “long-term moisturizing” claim has different design requirements than a 12-week study for a US “clinically tested” marketing statement or a China NMPA filing under NMPA Cosmetic Regulation.

Here’s how we structure a 12-week hydration study for a leave-on moisturizer or serum:

Subjects: 45–50 subjects, female, 30–55 years, Fitzpatrick I–IV, baseline Corneometer < 40 AU, no active dermatological conditions. Washout: 7 days minimum from all leave-on moisturizers.

Design: Randomized, double-blind, vehicle-controlled, split-face or parallel group depending on the product format. Split-face works well for serums and light emulsions. For richer creams, parallel group is cleaner because occlusion effects can migrate across the face midline.

Measurement timepoints: Baseline (T0), Week 2, Week 4, Week 8, Week 12. At each visit: Corneometer (3 readings per site, averaged), TEWL, Skicon, and consumer perception questionnaire. Photography at T0, Week 4, and Week 12.

Primary endpoint: Mean percentage change in Corneometer AU from baseline at Week 12 versus vehicle. Secondary endpoints: TEWL reduction, consumer perception scores, photography grading by blinded dermatologist.

Statistical analysis: Paired t-test or Wilcoxon signed-rank for within-subject comparisons. ANCOVA for parallel group designs, with baseline as covariate. Significance threshold p < 0.05. We also report effect size (Cohen’s d) because p-values alone don’t tell you whether the difference is clinically meaningful.

Failure mode we’ve seen: One pilot study at 500g lab scale showed excellent Corneometer response in internal testing. At 200kg production scale, the emulsifier ratio shifted slightly due to mixing shear differences, and the humectant release profile changed. By week 4 of the clinical study, the active arm was performing only marginally better than vehicle. We caught it because we ran a parallel stability and in-vitro release check alongside the clinical study. Most brands don’t do that. They should.

The 12-week timeline also needs to account for ICH Stability Guidelines — your clinical batch should be the same batch going into accelerated stability testing. If the product fails stability at week 8 of a 12-week study, you have a problem. We build the stability and clinical timelines in parallel from day one.

For brands targeting the EU market, the study report should follow the COLIPA/CTFA guidelines format and include a full statistical appendix. For the US market, the FDA doesn’t require pre-market substantiation submission, but the data needs to exist and be defensible if challenged. For China, NMPA requires specific testing formats for functional claims — the study design needs to be aligned with GB/T standards from the start, not retrofitted afterward.

See our detailed notes on barrier repair and sensitive skin formulation for how barrier function data integrates with hydration claim packages.

Formulation Notes for Brand Partners #

What market? What are you expecting on-pack? Those are the first two questions we ask every brand that briefs us on a hydration product. “72-hour hydration” in the EU requires a different study design than “clinically tested for moisture” in the US, and both are different from what NMPA expects for a functional claim in China. The claim drives the protocol, and the protocol has to be decided before we finalize the formula — not after.

In terms of ingredient architecture, the measurement method should inform your formulation strategy. If you’re using Corneometer as your primary endpoint, you want a humectant system that genuinely increases stratum corneum water content — sodium hyaluronate at 0.5–2%, glycerin at 3–8%, or a polyglutamic acid layer. If you’re also claiming barrier repair, you need ceramide NP/AP/EOP at meaningful levels (typically 0.5–1.5% total ceramide complex) and TEWL reduction data to back it.

One thing we push back on regularly: brands that want to use a film-forming polymer to boost Corneometer readings without a real humectant system underneath. It works at T2. It doesn’t hold at T8. And it definitely doesn’t hold at T24. The Skicon will tell you the truth even when the Corneometer looks acceptable.

Budget for the study early. A properly designed 40-subject, 12-week study with a qualified CRO runs roughly $18,000–$35,000 USD depending on geography and measurement panel. That’s before photography analysis. It’s not optional if you’re making a time-specific hydration claim in a regulated market.

Frequently Asked Questions #

Q: We want to put “72-hour hydration” on pack — what does the study actually need to show?

You need Corneometer data at T72 showing statistically significant improvement over baseline or vehicle, with subjects not reapplying the product after the initial application. Minimum 30 subjects, controlled environment. The T72 timepoint is the one that gets scrutinized — make sure your formula actually holds that long before you commit to the claim.

Q: Can we use the same study data for EU, US, and China market claims?

Partially. The instrumental data (Corneometer, TEWL) is generally accepted across markets. The study design format and report structure need to be adapted — NMPA has specific GB/T-aligned requirements that a standard COLIPA-format report doesn’t automatically satisfy. Budget for a regulatory gap analysis before you assume one study covers all three markets.

Q: How many subjects do we actually need — we’ve seen studies with as few as 20?

Twenty subjects will get you a p-value if your effect size is large enough, but it won’t survive retailer scrutiny or a regulatory challenge. We recommend 40–50 for a primary claim study. The extra 10–20 subjects cost maybe $3,000–$5,000 more and they buy you statistical credibility that’s worth far more than that.

Q: Our lab prototype showed great Corneometer results — can we use that data for the claim?

No. Internal lab testing on 5–10 subjects in uncontrolled conditions is development data, not claim substantiation data. It’s useful for formula selection, but a claim dossier requires a GCP-compliant study at a qualified CRO with a registered protocol. The two are completely different things.

Q: What’s the minimum Corneometer improvement we need to see for a meaningful claim?

In our experience, you need at least a 15–20% increase from baseline to make a claim that reads as meaningful to consumers and holds up to regulatory review. Below 10% is statistically significant in a large panel but practically unimpressive. The sweet spot for a strong “clinically proven hydration” claim is 25%+ at the primary timepoint, with the effect maintained through the final visit.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.